化合物 T16544 T16544

Product Introduction
Bioactivity


英文名: Pivalopril

描述: Pivalopril is a new orally active inhibitor of angiotensin-converting enzyme.

体内活性: Pivalopril is a new compound with a hindered sulfur group that has been compared to Captopril for oral angiotensin-converting enzyme (ACE) inhibition in rats and dogs and antihypertensive activity in rats. Pivalopril (incremental doses of 0.01-1.0 mg/kg, p.o.) produces a dose-related antagonism of AngI pressor effects, in conscious normotensive dogs. The ED50 is 0.17 mg/kg for Pivalopril and 0.06 mg/kg for Captopril. Pivalopril (100 mg/kg per day) decreases mean arterial pressure more effectively than Captopril (100 mg/kg per day). It is concluded that Pivalopril is a potent, orally effective ACE inhibitor and antihypertensive agent. In sodium-deficient, conscious spontaneously hypertensive rats (SHR), Pivalopril (1-100 mg/kg, p.o.) produces a dose-related reduction in mean arterial pressure. Pivalopril (0.03-1.0 mg/kg, orally [p.o.]) produces a dose-related antagonism of angiotensin I (AngI)-induced pressor effects, in separate groups of conscious normotensive rats. The ED50 for Pivalopril and Captopril is 0.1 mg/kg. At equieffective doses, the two compounds have similar durations of action. The potency and duration are similar to those of Captopril. In the sodium-replete SHR, 5 days of oral dosing with [2].

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

关键字: RHC3659 | RHC-3659 | RHC 3659 | Pivalopril

相关产品: Vicenin 3 | Leucosceptoside A | Plantainoside D | Angiotensin III, human, mouse | ZD 7155 hydrochloride | Saralasin acetate(34273-10-4 free base) | Vicenin 2 | Angiotensin II human | L-162,313 | Sacubitril/Valsartan

化合物 T16544 T16544信息由TargetMol中国为您提供，如您想了解更多关于化合物 T16544 T16544报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途